Machine Learning

A breakthrough semiconductor programs light like software, promising to solve AI's energy crisis and revolutionize robotics and next-gen communications.

A novel drug designed to eliminate stubborn cancer proteins enters human trials, offering a new strategy for ALK+ lung cancer patients facing resistance.

MOVA is expanding the smart home outdoors with a LiDAR-guided lawnmower and pool cleaner, promising to automate yard work and let you reclaim your weekend.

With pivotal trials advancing, key FDA alignment, and a strong cash position, Taysha Gene Therapies charts a clear path toward a potential breakthrough.

PairSoft's strategic acquisition of Nimbello bolsters its AI-driven financial automation, challenging competitors in the consolidating procure-to-pay market.

With the FDA mandating a move from animal testing, BioIVT is positioning itself at the center of the NAMs revolution with key industry events and research.

ImmunoBrain's novel immunotherapy for Alzheimer's avoids key safety issues of other drugs and shows positive biomarker data in a Phase 1b trial.

With Saumay Kumar as new CEO and Timothy Kelley as CSO, TeleRay is betting a dual-leadership model will accelerate growth and define the future of virtual care.

A new report reveals a 67% surge in mobile fraud, with sophisticated malware targeting over 1,200 banking apps to drain accounts directly from your phone.

A new AI platform, QuantumReady™, claims to automate the race against quantum threats, helping financial giants meet urgent regulatory deadlines.

A landmark deal for two small GEO satellites offers nations a new, capital-efficient path to strategic autonomy and control of their orbital assets.

Annovis Bio's new trial for buntanetap uses an AI-powered Apple Watch app to track symptoms, aiming for more precise data in the race for a cure.

A novel blood test from C2N Diagnostics, used in a major Alzheimer's trial, shows promise in predicting disease progression, heralding a new era of precision medicine.

A new report reveals a massive disparity in cloud firewall protection, with most failing to stop advanced evasion tactics, leaving enterprises exposed.

Brazil's real estate giant QuintoAndar is the first in Latin America to launch a ChatGPT app, leveraging the country's AI boom to redefine property search.

A new biotech spins out with a novel drug class aiming to provide healthier, more durable weight loss and combat cancer-related wasting syndrome.

Ractigen's RAG-01 advances with NMPA approval, using RNA activation to fight bladder cancer by targeting a previously 'undruggable' gene.

A new drug shows unprecedented activity against all common cold viruses, a major breakthrough for millions suffering from chronic lung diseases.

A new startup from security veterans says it can stop data theft before it happens by moving threat detection from the cloud directly onto the endpoint.

Quebec’s new budget maintains support for its vital life sciences sector, but industry leaders warn new tax rules could hinder innovation for small firms.